Pirouette Pharma

Portsmouth, NH · Founded 2017 · Privately Held (backing)

Developer of automated injectors designed for the emergency treatment of severe allergic reactions. Pirouette Pharma is based in Portsmouth, NH and was founded in 2017. It was valued at $95 million at its Equity Crowdfunding in Feb 2026, the last priced event on record. It has raised $22.9 million across 2 recorded rounds; the latest was a $1.1 million seed round in Mar 2026.

PMV mark · valuation
$95.0M
Oct 2026
Priced at
its Equity Crowdfunding
Feb 2026
Total raised
$22.9M
Last round
Seed Round
Mar 2026
Cap table — not yet on record

Pirouette Pharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Pirouette Pharma with a free account
  • ·The complete investor list: 20 names
  • ·Watch Pirouette Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Pirouette Pharma

Where does Pirouette Pharma's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Pirouette Pharma's 2 recorded funding rounds.